CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state-of-the art production facilities.

News Releases

News Releases

CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

Company Avoids Dilution to Stockholders Las Vegas, NV – (Globe Newswire – December 5, 2017) – CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the December 2017 installment obligation under its March 1, 2017 Convertible Promissory Note (the “Note”) in cash, thus avoiding the lender’s conversion … Continue reading CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

CV Sciences, Inc. to Present at the 10th Annual LD Micro Main Event

LOS ANGELES, CA / ACCESSWIRE / November 28, 2017 / CV Sciences, Inc., (OTCQB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil and developer of specialty pharmaceutical therapeutics, announced today that it will be presenting at the 10th annual LD Micro Main Event on Wednesday, December 6th at 10:30 AM PST / 1:30 PM EST … Continue reading CV Sciences, Inc. to Present at the 10th Annual LD Micro Main Event

CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL – December 1-3, 2017

Company enters its 3rd year exhibiting its industry-dominating brand, PlusCBD Oil™ at the Southeastern Regional Natural Health Retailer Conference and Expo. LAS VEGAS, NV — (Globe Newswire – November 21, 2017) – CV Sciences, Inc. (OTCBB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil, announces that its industry dominating brand of finished … Continue reading CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL – December 1-3, 2017

CV Sciences, Inc. Named One of North America’s Fastest Growing Companies on Deloitte’s 2017 Technology Fast 500™

Award recognizes 500 of the fastest growing companies in North America from 2013 to 2016 LAS VEGAS, NV – November 14, 2017 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil and developer of specialty pharmaceutical therapeutics, announced it has been named on Deloitte’s Technology Fast … Continue reading CV Sciences, Inc. Named One of North America’s Fastest Growing Companies on Deloitte’s 2017 Technology Fast 500™

CV Sciences, Inc. Reports Third Quarter 2017 Financial Results

– Record Quarter for all Financial Performance Metrics – Management to Host Webcast on November 8, 2017 to Discuss Q3 2017 Operating Results Las Vegas, NV – November 8, 2017 – CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today its financial results for the third quarter and nine months ended … Continue reading CV Sciences, Inc. Reports Third Quarter 2017 Financial Results

CV Sciences, Inc. Repays Convertible Debt

Company Satisfies Obligations on a Portion of its Outstanding Convertible Debt, Avoiding Dilution to Stockholders LAS VEGAS, NV — (Globe Newswire — October 17, 2017) – CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”), market-leading supplier and manufacturer of hemp-derived cannabidiol (CBD) products and developer of specialty pharmaceutical therapeutics, announced today that … Continue reading CV Sciences, Inc. Repays Convertible Debt

CV Sciences, Inc. to Exhibit at the 2017 Academy of Integrative Health & Medicine Annual Conference in San Diego, CA – October 22-25, 2017

Company Continues to Expand Its Distribution Network to Health Care Practitioners focused on Integrative and Natural Health Modalities   LAS VEGAS, NV–(Globe Newswire – October 10, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”), today announced that its industry-dominating brand of hemp-derived cannabidiol (CBD) oil finished products, PlusCBD Oil™, … Continue reading CV Sciences, Inc. to Exhibit at the 2017 Academy of Integrative Health & Medicine Annual Conference in San Diego, CA – October 22-25, 2017

CV Sciences, Inc. Announces its Platinum Sponsorship of Natural Products Association Expo Northwest in Portland, OR – October 13-14, 2017

Company enters its 3rd year exhibiting its industry-dominating brand, PlusCBD Oil™ at the Regional Natural Health Retailer Conference and Expo.  LAS VEGAS, NV — (Globe Newswire – October 3, 2017) – CV Sciences, Inc. (OTCBB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil, announces that its industry dominating brand of finished products, … Continue reading CV Sciences, Inc. Announces its Platinum Sponsorship of Natural Products Association Expo Northwest in Portland, OR – October 13-14, 2017

CV Sciences, Inc. to Present at The MicroCap Conference on October 5th at the Essex House in New York City

(Accesswire — September 28, 2017) CV Sciences, Inc. (CVSI) (the “Company,” “CV Sciences,” “our” or “we”), market-leading supplier and manufacturer of hemp-derived cannabidiol (CBD) products and developer of specialty pharmaceutical therapeutics, will be presenting at this year’s MicroCap Conference on October 5th in New York City. Joseph Dowling, Chief Financial Officer of CV Sciences, Inc. will be … Continue reading CV Sciences, Inc. to Present at The MicroCap Conference on October 5th at the Essex House in New York City

CV Sciences, Inc. Comments on Latest Research Citing Cannabidiol in Reducing the Risk of Post-Traumatic Stress Disorder

LAS VEGAS, NV—(GlobeNewswire – September 26, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”) is pleased to highlight yet another study identifying additional therapeutic opportunities of cannabidiol (CBD), which include the potential to prevent post-traumatic stress disorder (PTSD). Researchers at the Federal University of Parana, Santa Catarina, and the … Continue reading CV Sciences, Inc. Comments on Latest Research Citing Cannabidiol in Reducing the Risk of Post-Traumatic Stress Disorder